Pain-Related Anxiety-Like Behavior Requires CRF1 Receptors in the Amygdala
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Corticotropin-releasing factor receptor CRF1 has been implicated in the neurobiological mechanisms of anxiety and depression. The amygdala plays an important role in affective states and disorders such as anxiety and depression. The amygdala is also emerging as a neural substrate of pain affect. However, the involvement of the amygdala in the interaction of pain and anxiety remains to be determined. This study tested the hypothesis that CRF1 receptors in the amygdala are critically involved in pain-related anxiety. Anxiety-like behavior was determined in adult male rats using the elevated plus maze (EPM) test. The open-arm preference (ratio of open arm entries to the total number of entries) was measured. Nocifensive behavior was assessed by measuring hindlimb withdrawal thresholds for noxious mechanical stimulation of the knee. Measurements were made in normal rats and in rats with arthritis induced in one knee by intraarticular injections of kaolin/carrageenan. A selective CRF1 receptor antagonist (NBI27914) or vehicle was administered systemically (i.p.) or into the central nucleus of the amygdala (CeA, by microdialysis). The arthritis group showed a decreased preference for the open arms in the EPM and decreased hindlimb withdrawal thresholds. Systemic or intraamygdalar (into the CeA) administration of NBI27914, but not vehicle, inhibited anxiety-like behavior and nocifensive pain responses, nearly reversing the arthritis pain-related changes. This study shows for the first time that CRF1 receptors in the amygdala contribute critically to pain-related anxiety-like behavior and nocifensive responses in a model of arthritic pain. The results are a direct demonstration that the clinically well-documented relationship between pain and anxiety involves the amygdala.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 1×
“The neural pathways and mechanisms involved in pain-related anxiety remain to be determined, but the amygdala is known to play a key role in emotional-affective behavior and anxiety disorders [4-6].”
BackgroundCRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
State-dependent opioid control of pain
Fields, H. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1431 · Cited by 946 · cited 1×
“The amygdala is also believed to be a key substrate of the reciprocal relationship between pain and affective states and disorders such as anxiety [3,10,12,13].”
BackgroundBaliki, M. N., Chialvo, D. R., Geha, P. Y., Levy, R. M., Harden, R. N., Parrish, T. B., & Apkarian, A. V. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3576-06.2006 · Cited by 756
The amygdala and persistent pain
Neugebauer, V., Li, W., Bird, G. C., & Han, J. S. (2004) · The Neuroscientist · doi:10.1177/1073858403261077 · Cited by 719 · cited 2×
“Importantly, the amygdala is emerging as an important element of the brain network involved in the emotionalaffective component of pain [7-11].”
BackgroundSelf-citationZobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Pain pathways and parabrachial circuits in the rat.
Gauriau, C., & Bernard, J. (2002) · Experimental Physiology · doi:10.1113/eph8702357 · Cited by 572
The Role of the Central Nucleus of the Amygdala in Mediating Fear and Anxiety in the Primate
Kalin, N. H., Shelton, S. E., & Davidson, R. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0292-04.2004 · Cited by 406 · cited 1×
“The neural pathways and mechanisms involved in pain-related anxiety remain to be determined, but the amygdala is known to play a key role in emotional-affective behavior and anxiety disorders [4-6].”
BackgroundSynaptic Mechanisms of Associative Memory in the Amygdala
Maren, S. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.009 · Cited by 341
Limbic and HPA axis function in an animal model of chronic neuropathic pain
Ulrich-Lai, Y. M., Xie, W., Meij, J. T. A., Dolgas, C. M., Yu, L., & Herman, J. P. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.012 · Cited by 146 · cited 2×
“Recent biochemical [45-47] and behavioral [48-51] studies point to the amygdala as an important site for the pain-modulatory effects of CRF.”
BackgroundMcNally, G. P., & Akil, H. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00105-7 · Cited by 141 · cited 2×
“Recent biochemical [45-47] and behavioral [48-51] studies point to the amygdala as an important site for the pain-modulatory effects of CRF.”
Background
Cited by
Ossipov, M. H., Dussor, G. O., & Porreca, F. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43766 · Cited by 1,159
The influence of negative emotions on pain: Behavioral effects and neural mechanisms
Wiech, K., & Tracey, I. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.059 · Cited by 614
Neurobiology of opioid addiction: Opponent process, hyperkatifeia, and negative reinforcement
Koob, G. F. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.023 · Cited by 477
Neugebauer, V. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_13 · Cited by 399
Self-citationDe Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
Metadata
- Authors
- Ji, G., Fu, Y., Ruppert, K. A., & Neugebauer, V.
- Venue
- Molecular Pain
- Publisher
- SAGE Publications
- Published
- 2007-01-01
- Volume
- 3
- Pages
- 13-13
- ISSN
- 1744-8069 (ISSN-L)
- OpenAlex
- W2103249556
- Cited by
- 138
- References
- 11
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.